Skip to main content
. 2016 Feb 5;11(2):e0147713. doi: 10.1371/journal.pone.0147713

Table 2. Comparison between the TIVA and inhalation groups.

TIVA group (n = 69) Inhalation group (n = 87) p value
Patient variables
    Male, no. 64 83 0.510
    Age, yr 52.80±10.93 52.11±8.82 0.667
    BMI, kg/m2 24.07 ±4.00 23.66 ± 4.09 0.325
    ASA class III 9 7 0.426
    Smoker, no 22 25 0.803
    Preop C/T 19 34 0.180
    Preop R/T 22 30 0.864
    Hypertension 24 28 0.864
    Diabetes mellitus 10 14 0.959
    Anesthesia variables
    Mean CVP, mmHg 7.04 ± 3.13 8.53 ± 3.23 0.0039
    Total U/O, ml 1509.86 ± 1063.95 2074.48 ± 1115.10 0.0001
    Total crystalloid, ml 4172.46 ± 1534.95 5183.91 ± 1416.40 < 0.0001
    Total colloid, ml 572.46 ± 335.14 994.25 ± 434.65 < 0.0001
    Blood loss, ml 918.77 ± 656.84 859.71 ± 486.47 0.707
    I/O, ml 2316.30 ± 1056.73 3243.97 ± 1282.99 < 0.0001
    Anesthesia duration, hr 11.02 ± 2.84 11.70± 1.96 0.017

BMI, Body mass index; ASA, classification of American society for anesthesiologist physical status; Smoker, current smoker at the time of admission; Preop C/T, Preoperative chemotherapy; Preop R/T, Preoperative radiotherapy; TIVA, Total Intravenous anesthesia; CVP, Central venous pressure; U/O, urine output;

I/O, total fluid balance; Significant at p < 0.05 level